Marel hf.
The deadline for declaring candidature for the Marel hf. Board of Directors passed on 3 March at 4pm GMT. The Virtual Annual General Meeting 2021 will be held at 4pm GMT on Wednesday 17 March 2021.
The seven candidates for the Board of Directors are the following:
Ann Elisabeth Savage, Spalding, UK
Arnar Thor Masson, Reykjavík, Iceland
Astvaldur Johannsson, Seltjarnarnes, Iceland
Lillie Li Valeur, Vejle, Denmark
Dr Olafur Gudmundsson, Princeton, New Jersey, US
Dr Svafa Grönfeldt, Boston, US
Ton van der Laan, Berlicum, Netherlands
For further information on each candidate, please find a short bio attached and archived on the AGM 2021 page on the Company´s website: marel.com/agm
According to the Articles of Association of the Company, the Board of Directors shall be comprised of 5 to 7 members. The Board of Directors proposes that the Company’s shareholders elect seven directors to serve on the Board of Directors.
Notice to submit proposals or matters to be considered by the meeting has passed, as per Article 4.21 of the Company's Articles of Association.
Final agenda and proposals to the meeting are hereby attached.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alkane Resources Limited19.12.2025 01:33:33 CET | Press release
Alkane Doubles the Tested Depth Extent of the Storheden Deposit at Björkdal
eGain Corporation18.12.2025 22:48:21 CET | Press release
Achmea Selects eGain AI Knowledge Hub and AI Agent to Power Digital Transformation
Parker University18.12.2025 22:27:59 CET | Press release
Parker Seminars Announces Las Vegas 2026 (Feb. 26–28): The World’s Largest Chiropractic & Healthcare Event Celebrates 75 Years
Galapagos NV18.12.2025 22:01:00 CET | Press release
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Bavarian Nordic A/S18.12.2025 20:41:21 CET | Pressemeddelelse
Bavarian Nordic iværksætter nyt langsigtet incitamentsprogram for koncernledelsen og udvalgte medarbejdere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
